Search Results Search Sort by RelevanceMost Recent Viewpoint Apr 2014 Inappropriate Obstructions to Access: The FDA’s Handling of Plan B Susan F. Wood, PhD The FDA’s approval for over-the-counter sales of emergency contraception marked a departure from its standard approval process and obstructed access to a safe and effective drug. That departure could set a dangerous precedent for future decisions. Virtual Mentor. 2014;16(4):295-301. doi: 10.1001/virtualmentor.2014.16.4.oped1-1404. Viewpoint May 2016 Hospital Ethics Committees, Consultants, and Courts George Annas, JD, MPH and Michael Grodin, MD AMA J Ethics. 2016;18(5):554-559. doi: 10.1001/journalofethics.2016.18.5.sect1-1605.